All news from Emergency Medicine

Heart Attacks More Common In Younger People

Heart attacks once characterized as a part of "old man's disease" are increasingly occurring in younger people, especially women, according to new research. The study, presented Sunday at the American Heart Association's Scientific Sessions meeting in Chicago and published in the AHA journal Circulation, sought to investigate heart attacks in the young, a group frequently overlooked in cardiovascular research.

Stories of The Victims of Gun Violence

Invited to share their personal stories, victims of urban gun violence describe living with violence as a "common everyday experience" and feeling abandoned by police and other societal institutions, reports a study in the November/December Journal of Trauma Nursing, official publication of the Society of Trauma Nurses.

World's First Medical Imaging Scanner

EXPLORER, the world's first medical imaging scanner that can capture a 3-D picture of the whole human body at once, has produced its first scans. The brainchild of UC Davis scientists Simon Cherry and Ramsey Badawi, EXPLORER is a combined positron emission tomography (PET) and x-ray computed tomography (CT) scanner that can image the entire body at the same time.

First Blood-Based Biomarker Treats Prostate Cancer

The most aggressive type of prostate cancer, castration-resistant prostate cancer, can be treated via two therapies: taxanes or hormone treatment. Until recently, there were no comparative studies between the two, and the decision on which treatment to use was done empirically and based on the patient's preferences.

New Antibody Immunotherapy Fights Against Cancer

Scientists at the University of Southampton have developed a new antibody that could hold the key to unlocking cancer's defence against the body's immune system. In a new study published in Immunity, the team, which is based at the Centre for Cancer Immunology, engineered antibodies to target a particularly significant immune receptor called 4-1BB, which can activate killer T-cells to find and destroy cancer cells.